The impact of “faster aspart” on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump
Background and aims: Post-prandial glucose control is essential to achieve metabolic goals in patients with type 1 diabetes mellitus (T1DM). The new “faster aspart” insulin has a pharmacological profile noted for its faster absorption and onset of action, and increased early availability, resulting...
Guardado en:
Autores principales: | Jesús González de Buitrago Amigo, Ana González García, Paula Díaz Fernández, Mercedes Fernández Llamas, María Luz Tejado Bravo, Jorge M. de Nicolás Jiménez, Marta Ferrer Lozano |
---|---|
Formato: | article |
Lenguaje: | ES |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07fb0835ce3e47f6b07cd8c755506b44 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impacto de faster aspart sobre el control glucémico en niños y adolescentes con diabetes tipo 1 en tratamiento con un sistema integrado
por: Jesús González de Buitrago Amigo, et al.
Publicado: (2021) -
Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
por: Hanne Haahr, et al.
Publicado: (2020) -
Use of short-acting insulin aspart in managing older people with diabetes
por: Eltayeb Marouf, et al.
Publicado: (2009) -
ASPARTATE AMINOTRANSFERASE PLATELET RATIO INDEX AS A NON-INVASIVE PREDICTOR FOR ESOPHAGEAL VARICES
por: Syed Hassan Raza, et al.
Publicado: (2019) -
Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)